{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:16:49Z","timestamp":1784557009142,"version":"3.55.0"},"reference-count":0,"publisher":"Bioscientifica","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["ec.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,2]]},"abstract":"<jats:p>\n                    Patients with chronic immune-mediated arthritis exhibit abnormal hypothalamo-pituitary-adrenal (HPA) axis activity. The basis for this abnormality is not known. Immune-mediated arthritis is associated with increased extra-adrenal synthesis of active glucocorticoids by the 11\u03b2-hydroxysteroid dehydrogenase type 1 (11\u03b2-HSD1) enzyme. 11\u03b2-HSD1 is expressed in the central nervous system, including regions involved in HPA axis regulation. We examined whether altered 11\u03b2-HSD1 expression within these regions contributes to HPA axis dysregulation during arthritis. The expression of 11\u03b2-HSD1, and other components of glucocorticoid signaling, were examined in various brain regions and the pituitary gland of mice with experimentally induced arthritis. Two arthritis protocols were employed: The K\/BxN spontaneous arthritis model for chronic arthritis and the K\/BxN serum transfer arthritis model for acute arthritis. 11\u03b2-HSD1 mRNA (\n                    <jats:italic>Hsd11b1<\/jats:italic>\n                    ) was expressed in the hippocampus, hypothalamus, cortex, cerebellum and pituitary gland. Hypothalamic\n                    <jats:italic>Hsd11b1<\/jats:italic>\n                    expression did not change in response to arthritis in either model. Pituitary\n                    <jats:italic>Hsd11b1<\/jats:italic>\n                    expression was however significantly increased in both chronic and acute arthritis models. Hippocampal\n                    <jats:italic>Hsd11b1<\/jats:italic>\n                    was decreased in acute but not chronic arthritis. Chronic, but not acute, arthritis was associated with a reduction in hypothalamic corticotropin-releasing hormone and arginine vasopressin expression. In both models, serum adrenocorticotropic hormone and corticosterone levels were no different from non-inflammatory controls. These findings demonstrate inflammation-dependent regulation of\n                    <jats:italic>Hsd11b1<\/jats:italic>\n                    expression in the pituitary gland and hippocampus. The upregulation of 11\u03b2-HSD1 expression in the pituitary during both chronic and acute arthritis, and thus, an increase in glucocorticoid negative feedback, could contribute to the abnormalities in HPA axis activity seen in immune-mediated arthritis.\n                  <\/jats:p>","DOI":"10.1530\/ec-17-0361","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T20:10:49Z","timestamp":1517429449000},"page":"385-394","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-10","source":"Crossref","is-referenced-by-count":13,"title":["Role of 11\u03b2-HSD type 1 in abnormal HPA axis activity during immune-mediated arthritis"],"prefix":"10.1530","volume":"7","author":[{"given":"Janko","family":"Sattler","sequence":"first","affiliation":[{"name":"1Adrenal Steroid Group, ANZAC Research Institute, University of Sydney, Sydney, NSW, Australia"},{"name":"2Department of Rheumatology and Clinical Immunology, Charit\u00e9-University Medicine, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinwen","family":"Tu","sequence":"additional","affiliation":[{"name":"1Adrenal Steroid Group, ANZAC Research Institute, University of Sydney, Sydney, NSW, Australia"},{"name":"3Bone Research Program, ANZAC Research Institute, University of Sydney, Sydney, NSW, Australia"},{"name":"4Concord Clinical School, The University of Sydney, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihani","family":"Stoner","sequence":"additional","affiliation":[{"name":"3Bone Research Program, ANZAC Research Institute, University of Sydney, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingbao","family":"Li","sequence":"additional","affiliation":[{"name":"3Bone Research Program, ANZAC Research Institute, University of Sydney, Sydney, NSW, Australia"},{"name":"5Key Laboratory for Space Bioscience and Biotechnology, Institute of Special Environmental Biophysics, School of Life Sciences, Northwestern Polytechnical University, Shaanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Buttgereit","sequence":"additional","affiliation":[{"name":"2Department of Rheumatology and Clinical Immunology, Charit\u00e9-University Medicine, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus J","family":"Seibel","sequence":"additional","affiliation":[{"name":"3Bone Research Program, ANZAC Research Institute, University of Sydney, Sydney, NSW, Australia"},{"name":"4Concord Clinical School, The University of Sydney, Sydney, Australia"},{"name":"6Department of Endocrinology & Metabolism, Concord Hospital, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhou","sequence":"additional","affiliation":[{"name":"3Bone Research Program, ANZAC Research Institute, University of Sydney, Sydney, NSW, Australia"},{"name":"4Concord Clinical School, The University of Sydney, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S","family":"Cooper","sequence":"additional","affiliation":[{"name":"1Adrenal Steroid Group, ANZAC Research Institute, University of Sydney, Sydney, NSW, Australia"},{"name":"4Concord Clinical School, The University of Sydney, Sydney, Australia"},{"name":"6Department of Endocrinology & Metabolism, Concord Hospital, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","container-title":["Endocrine Connections"],"original-title":[],"link":[{"URL":"https:\/\/ec.bioscientifica.com\/view\/journals\/ec\/7\/2\/EC-17-0361.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ec.bioscientifica.com\/downloadpdf\/journals\/ec\/7\/2\/EC-17-0361.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:42:41Z","timestamp":1784554961000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/ec\/article\/7\/2\/385-394\/277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":0,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.1530\/ec-17-0361","relation":{},"ISSN":["2049-3614"],"issn-type":[{"value":"2049-3614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2]]}}}